SELECT B — Selectimmune Pharma AB Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- SEK41.38m
- SEK35.54m
Annual balance sheet for Selectimmune Pharma AB, fiscal year end - June 30th, SEK millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.049 | 34.9 | 23 | 26.6 | 11.2 |
Net Total Receivables | 0 | 1.4 | 0.104 | 0.63 | 0.6 |
Prepaid Expenses | |||||
Total Current Assets | 0.049 | 38.3 | 23.2 | 27.4 | 11.9 |
Net Property, Plant And Equipment | — | — | 1.92 | 1.52 | 1.12 |
Total Assets | 0.049 | 38.3 | 25.1 | 28.9 | 13 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.012 | 5.65 | 0.712 | 3.02 | 1.22 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.012 | 5.65 | 0.712 | 3.02 | 1.22 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.037 | 32.6 | 24.4 | 25.9 | 11.8 |
Total Liabilities & Shareholders' Equity | 0.049 | 38.3 | 25.1 | 28.9 | 13 |
Total Common Shares Outstanding |